Published :
Tables : 51
Figures : 44
Category : Healthcare
No. of Pages : 233
Report Code : HC-U4601
Latin America In Vitro Diagnostics (IVD) Market is poised to value over USD 6.1 billion by 2027 end at a CAGR of over 7.7% during the forecast period 2020 to 2027 FutureWise Market Research has instantiated a report that provides an intricate analysis of Latin America In Vitro Diagnostics (IVD) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Latin America In Vitro Diagnostics (IVD) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Latin America In Vitro Diagnostics (IVD) Market: • Roche Diagnostics (Switzerland) • Siemens Healthcare GmbH (Germany) • Qiagen N.V (Germany) • Biomérieux S.A. (France) • Abbott Laboratories (U.S.) • Becton, Dickinson And Company (U.S.) • Bio-Rad Laboratories, Inc. (U.S.) • Wama Diagnóstica (Brazil) • Labin Perú S.A. (Peru) • WM Argentina SA (Argentina) • Belomed SRL (Peru) • Wiener Laboratorios SAIC (Argentina) • Diagnóstica Peruana SAC (Peru) • Diamed Argentina (Argentina) • Andina Medica (Peru) • Grifols Chile S.A (Chile). (Note: The list of the major players will be updated with the latest market scenario and trends) Latin America In Vitro Diagnostics (IVD) Market Segmentation: By Product • Reagents, Assays, and Kits • Instruments/Analyzers • Software and Services By Technology • Immunoassay/Immunochemistry o Enzyme-Linked Immunosorbent Assay (ELISA) o Radioimmunoassay o Rapid Tests o Western Blotting o Other Immunochemistry Tests • Clinical Chemistry o Metabolic Panel o Electrolyte Panel o Liver Panel o Lipid Profile o Renal Profile o Thyroid Function Panel • Molecular Diagnostics o Polymerase Chain Reaction (PCR) o Isothermal Nucleic Acid Amplification Technology (INAAT) o Microarrays o DNA Sequencing & Next-Generation Sequencing o Other Molecular Diagnostic Tests • Microbiology • Hematology • Coagulation & Hemostasis • Urinalysis • Other IVD Technologies By Application • Infectious Diseases • Oncology • Endocrinology • Diabetes • Cardiology • Other Applications By End User • Hospital Laboratories • Diagnostic Reference Laboratories • Point-of-Care (POC) Testing • Academic & Research Institutes By Region • Brazil • Venezuela • Argentina • Rest of Latin America Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Latin America In Vitro Diagnostics (IVD) Market By Product, By Technology, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— Brazil, Venezuela, Argentina, Rest of Latin America • To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Latin America In Vitro Diagnostics (IVD) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Latin America In Vitro Diagnostics (IVD) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Latin America In Vitro Diagnostics (IVD) Market: • Roche Diagnostics (Switzerland) • Siemens Healthcare GmbH (Germany) • Qiagen N.V (Germany) • Biomérieux S.A. (France) • Abbott Laboratories (U.S.) • Becton, Dickinson And Company (U.S.) • Bio-Rad Laboratories, Inc. (U.S.) • Wama Diagnóstica (Brazil) • Labin Perú S.A. (Peru) • WM Argentina SA (Argentina) • Belomed SRL (Peru) • Wiener Laboratorios SAIC (Argentina) • Diagnóstica Peruana SAC (Peru) • Diamed Argentina (Argentina) • Andina Medica (Peru) • Grifols Chile S.A (Chile). (Note: The list of the major players will be updated with the latest market scenario and trends) Latin America In Vitro Diagnostics (IVD) Market Segmentation: By Product • Reagents, Assays, and Kits • Instruments/Analyzers • Software and Services By Technology • Immunoassay/Immunochemistry o Enzyme-Linked Immunosorbent Assay (ELISA) o Radioimmunoassay o Rapid Tests o Western Blotting o Other Immunochemistry Tests • Clinical Chemistry o Metabolic Panel o Electrolyte Panel o Liver Panel o Lipid Profile o Renal Profile o Thyroid Function Panel • Molecular Diagnostics o Polymerase Chain Reaction (PCR) o Isothermal Nucleic Acid Amplification Technology (INAAT) o Microarrays o DNA Sequencing & Next-Generation Sequencing o Other Molecular Diagnostic Tests • Microbiology • Hematology • Coagulation & Hemostasis • Urinalysis • Other IVD Technologies By Application • Infectious Diseases • Oncology • Endocrinology • Diabetes • Cardiology • Other Applications By End User • Hospital Laboratories • Diagnostic Reference Laboratories • Point-of-Care (POC) Testing • Academic & Research Institutes By Region • Brazil • Venezuela • Argentina • Rest of Latin America Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Latin America In Vitro Diagnostics (IVD) Market By Product, By Technology, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— Brazil, Venezuela, Argentina, Rest of Latin America • To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Latin America In Vitro Diagnostics (IVD) Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Latin America In Vitro Diagnostics (IVD) Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Latin America In Vitro Diagnostics (IVD) Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Latin America In Vitro Diagnostics (IVD) Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Reagents, Assays, and Kits 7.2. Instruments/Analyzers 7.3. Software and Services 8. Latin America In Vitro Diagnostics (IVD) Market, By Technology Historical Analysis and Forecast 2020-2028 (USD Million) 8.1. Immunoassay/Immunochemistry 8.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 8.1.2. Radioimmunoassay 8.1.3. Rapid Tests 8.1.4. Western Blotting 8.1.5. Other Immunochemistry Tests 8.2. Clinical Chemistry 8.2.1. Metabolic Panel 8.2.2. Electrolyte Panel 8.2.3. Liver Panel 8.2.4. Lipid Profile 8.2.5. Renal Profile 8.2.6. Thyroid Function Panel 8.3. Molecular Diagnostics 8.3.1. Polymerase Chain Reaction (PCR) 8.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 8.3.3. Microarrays 8.3.4. DNA Sequencing & Next-Generation Sequencing 8.3.5. Other Molecular Diagnostic Tests 8.4. Microbiology 8.5. Hematology 8.6. Coagulation & Hemostasis 8.8. Urinalysis 8.8. Other IVD Technologies 9. Latin America In Vitro Diagnostics (IVD) Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Infectious Diseases 9.2. Oncology 9.3. Endocrinology 9.4. Diabetes 9.5. Cardiology 9.5. Other Applications 10. Latin America In Vitro Diagnostics (IVD) Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Mastectomy 10.2. Lumpectomy 10.3. Plastic Surgery 10.4. Breast Reconstruction 11. Latin America In Vitro Diagnostics (IVD) Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Market Share Analysis and Competitive Landscape 12.1. Latin America Landscape - Key Players, Revenue and Presence 12.2. Latin America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 12.3. Latin America Emerging Companies 12.4. Latin America - Market Share Analysis and Key Regional Players 12.5. Latin America Key Player - Growth Matrix 13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 13.1. Roche Diagnostics (Switzerland) 13.1.1. Company Overview 13.1.2. Product Portfolio 13.1.3. SWOT Analysis 13.1.4. Financial Overview 13.1.5. Strategic Overview 13.2. Siemens Healthcare GmbH (Germany) 13.2.1. Company Overview 13.2.2. Product Portfolio 13.2.3. SWOT Analysis 13.2.4. Financial Overview 13.2.5. Strategic Overview 13.3. Qiagen N.V (Germany) 13.3.1. Company Overview 13.3.2. Product Portfolio 13.3.3. SWOT Analysis 13.3.4. Financial Overview 13.3.5. Strategic Overview 13.4. Biomérieux S.A. (France) 13.4.1. Company Overview 13.4.2. Product Portfolio 13.4.3. SWOT Analysis 13.4.4. Financial Overview 13.4.5. Strategic Overview 13.5. Abbott Laboratories (U.S.) 13.5.1. Company Overview 13.5.2. Product Portfolio 13.5.3. SWOT Analysis 13.5.4. Financial Overview 13.5.5. Strategic Overview 13.6. Becton, Dickinson And Company (U.S.) 13.6.1. Company Overview 13.6.2. Product Portfolio 13.6.3. SWOT Analysis 13.6.4. Financial Overview 13.6.5. Strategic Overview 13.7. Bio-Rad Laboratories, Inc. (U.S.) 13.7.1. Company Overview 13.7.2. Product Portfolio 13.7.3. SWOT Analysis 13.7.4. Financial Overview 13.7.5. Strategic Overview 13.8. Wama Diagnóstica (Brazil) 13.8.1. Company Overview 13.8.2. Product Portfolio 13.8.3. SWOT Analysis 13.8.4. Financial Overview 13.8.5. Strategic Overview 13.9. Labin Perú S.A. (Peru) 13.9.1. Company Overview 13.9.2. Product Portfolio 13.9.3. SWOT Analysis 13.9.4. Financial Overview 13.9.5. Strategic Overview 13.10.WM Argentina SA (Argentina) 13.10.1.Company Overview 13.10.2.Product Portfolio 13.10.3.SWOT Analysis 13.10.4.Financial Overview 13.10.5.Strategic Overview 13.11.Belomed SRL (Peru) 13.11.1.Company Overview 13.11.2.Product Portfolio 13.11.3.SWOT Analysis 13.11.4.Financial Overview 13.11.5.Strategic Overview 13.12.Wiener Laboratorios SAIC (Argentina) 13.12.1.Company Overview 13.12.2.Product Portfolio 13.12.3.SWOT Analysis 13.12.4.Financial Overview 13.12.5.Strategic Overview 13.13.Diagnóstica Peruana SAC (Peru) 13.13.1.Company Overview 13.13.2.Product Portfolio 13.13.3.SWOT Analysis 13.13.4.Financial Overview 13.13.5.Strategic Overview 13.14.Diamed Argentina (Argentina) 13.14.1.Company Overview 13.14.2.Product Portfolio 13.14.3.SWOT Analysis 13.14.4.Financial Overview 13.14.5.Strategic Overview 13.15.Andina Medica (Peru) 13.15.1.Company Overview 13.15.2.Product Portfolio 13.15.3.SWOT Analysis 13.15.4.Financial Overview 13.15.5.Strategic Overview 13.16.Grifols Chile S.A (Chile). 13.16.1.Company Overview 13.16.2.Product Portfolio 13.16.3.SWOT Analysis 13.16.4.Financial Overview 13.16.5.Strategic Overview 14. Pre and Post COVID-19 Impact 14.1. Positive influence on the healthcare industry 14.2. The financial disruption of the manufacturing sector 14.3. Impact of COVID-19 on emerging companies 14.4. Significant mandates in the healthcare regulations initiated by administrations 14.5. The overall economic slowdown of the developing and developed nations 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics